Functional frontal lobectomy in the surgical treatment of pharmacoresistant frontal lobe epilepsy: how I do it.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
18 Jul 2024
Historique:
received: 18 03 2024
accepted: 23 06 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: epublish

Résumé

Frontal lobe epilepsy is pharmacoresistant in 30% of cases, constituting 10-20% of epilepsy surgeries. For cases of no lesional epilepsy (negative MRI), frontal lobectomy is a crucial treatment, historically involving Frontal Anatomical Lobectomy (AFL) with a 33.3% complication risk and 55.7% seizure control. We describe Frontal Functional Lobectomy (FFL), in which the boundaries are defined on the patient's functional cortico-subcortical areas, recognized with advanced intraoperative technologies such as tractography and navigated transcranial magnetic stimulation (nTMS). The FFL allows for a broader resection with a lower rate of postoperative complications than the AFL.

Sections du résumé

BACKGROUND BACKGROUND
Frontal lobe epilepsy is pharmacoresistant in 30% of cases, constituting 10-20% of epilepsy surgeries. For cases of no lesional epilepsy (negative MRI), frontal lobectomy is a crucial treatment, historically involving Frontal Anatomical Lobectomy (AFL) with a 33.3% complication risk and 55.7% seizure control.
METHODS METHODS
We describe Frontal Functional Lobectomy (FFL), in which the boundaries are defined on the patient's functional cortico-subcortical areas, recognized with advanced intraoperative technologies such as tractography and navigated transcranial magnetic stimulation (nTMS).
CONCLUSIONS CONCLUSIONS
The FFL allows for a broader resection with a lower rate of postoperative complications than the AFL.

Identifiants

pubmed: 39020068
doi: 10.1007/s00701-024-06176-x
pii: 10.1007/s00701-024-06176-x
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

299

Informations de copyright

© 2024. The Author(s).

Références

Englot DJ, Wang DD, Rolston JD, Shih TT, Chang EF (2012) Rates and predictors of long-term seizure freedom after frontal lobe epilepsy surgery: a systematic review and meta-analysis. J Neurosurg 116:1042–1048. https://doi.org/10.3171/2012.1.Jns111620
doi: 10.3171/2012.1.Jns111620 pubmed: 22304450
Hirata S, Morino M, Nakae S, Matsumoto T (2020) Surgical technique and outcome of extensive frontal lobectomy for treatment of intracable non-lesional frontal lobe epilepsy. Neurol Med Chir 60:17–25. https://doi.org/10.2176/nmc.oa.2018-0286
doi: 10.2176/nmc.oa.2018-0286
Jeha LE, Najm I, Bingaman W, Dinner D, Widdess-Walsh P, Lüders H (2007) Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain 130:574–584. https://doi.org/10.1093/brain/awl364
doi: 10.1093/brain/awl364 pubmed: 17209228
Matsumoto R, Nair DR, LaPresto E, Najm I, Bingaman W, Shibasaki H, Lüders HO (2004) Functional connectivity in the human language system: a cortico-cortical evoked potential study. Brain 127:2316–2330. https://doi.org/10.1093/brain/awh246
doi: 10.1093/brain/awh246 pubmed: 15269116
Taniguchi M, Cedzich C, Taniguchi M, Cedzich C, Schramm J (1993) Modification of cortical stimulation for motor evoked potentials under general anesthesia: technical description. Neurosurgery 32:219–226
doi: 10.1227/00006123-199302000-00011 pubmed: 8437660
Wen HT, Da Róz LM, Rhoton AL Jr, Castro LH, Teixeira MJ (2017) Frontal lobe decortication (Frontal Lobectomy with Ventricular Preservation) in epilepsy-part 1: anatomic landmarks and surgical technique. World Neurosurg 98:347–364. https://doi.org/10.1016/j.wneu.2016.10.090
doi: 10.1016/j.wneu.2016.10.090 pubmed: 27989972

Auteurs

Francesca Battista (F)

Department of Neurosurgery, Department of Neuroscience, Psychology, Drug Area and Child Health (NEUROFARBA), University of Florence, Careggi University Hospital, Florence, Italy.

Alice Esposito (A)

Department of Neurosurgery, Department of Neuroscience, Psychology, Drug Area and Child Health (NEUROFARBA), University of Florence, Careggi University Hospital, Florence, Italy.
University of Florence, School of Human Health Sciences, Firenze, Italia.

Giovanni Muscas (G)

Department of Neurosurgery, Department of Neuroscience, Psychology, Drug Area and Child Health (NEUROFARBA), University of Florence, Careggi University Hospital, Florence, Italy.

Alessandro Della Puppa (AD)

Department of Neurosurgery, Department of Neuroscience, Psychology, Drug Area and Child Health (NEUROFARBA), University of Florence, Careggi University Hospital, Florence, Italy. alessandro.dellapuppa@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH